Heart Failure and Edema Costs in Patiromer and Sodium Zirconium Cyclosilicate Users.

Kidney360 · 2024 · PMC11371352 · PMID 38837247

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

After accounting for medication cost, there was a PPPY trend showing $1428 higher costs in patients taking SZC than in patients taking patiromer; however, this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.